Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01270919 · ClinicalTrials.gov registry record · NA
A Prospective, Post-market, Multi-center Feasibility Study of the BioDuct® Meniscal Repair Device
A NA study, sponsored by Stryker Orthopaedics.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT01270919: Clinical Trial NA study, sponsored by Stryker Orthopaedics.
NCT01270919 is a NA study that was terminated before completion, run by Stryker Orthopaedics. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01270919, a NA study, was terminated before completion, sponsored by Stryker Orthopaedics.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
To demonstrate repair of the meniscus at 6 months, as evaluated by MRI, will be observed; and clinical qualitative assessments will improve from preoperative to postoperative time points with the BioDuct® Meniscal Repair Device.
Interventions
- DEVICE BioDuct Meniscal Repair Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2010-11 |
| Est. Completion | 2011-05 |
| Phase | NA |
Why NCT01270919 stopped before completion
NCT01270919 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which BioDuct Meniscal Repair Device is the first listed.
NCT01270919 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01270919 about?
NCT01270919 is a clinical study titled "A Prospective, Post-market, Multi-center Feasibility Study of the BioDuct® Meniscal Repair Device". To demonstrate repair of the meniscus at 6 months, as evaluated by MRI, will be observed; and clinical qualitative assessments will improve from preoperative to postoperative time points with the BioDuct® Meniscal Repair Device.
What is the current status of trial NCT01270919?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2010-11. Estimated completion is 2011-05.
What interventions are being tested in trial NCT01270919?
The interventions under investigation include: BioDuct Meniscal Repair Device (DEVICE).
Who is sponsoring clinical trial NCT01270919?
This trial is sponsored by Stryker Orthopaedics, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01270919's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia